Corient Capital Partners, LLC Metlife Inc Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Metlife Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 20,479 shares of MET stock, worth $1.64 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

20,479

Previous 19,537 4.82%

Holding current value

$1.64 Million

Previous $1.23 Million 4.81%

% of portfolio

0.1%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.01 - $68.52 $20,733 - $64,545	942 Added 4.82%	20,479 $1.29 Million
Q2 2022 Aug 12, 2022	BUY	$60.87 - $72.44 $205,984 - $245,136	3,384 Added 20.95%	19,537 $1.23 Million
Q1 2022 May 16, 2022	BUY	$61.96 - $71.63 $112,023 - $129,507	1,808 Added 12.6%	16,153 $1.14 Million
Q4 2021 Feb 11, 2022	BUY	$57.11 - $66.6 $79,782 - $93,040	1,397 Added 10.79%	14,345 $896,000
Q3 2021 Nov 16, 2021	SELL	$55.86 - $63.61 $57,256 - $65,200	-1,025 Reduced 7.34%	12,948 $799,000
Q2 2021 Aug 16, 2021	SELL	$58.3 - $67.16 $27,109 - $31,229	-465 Reduced 3.22%	13,973 $836,000
Q1 2021 May 17, 2021	BUY	$46.08 - $61.76 $29,122 - $39,032	632 Added 4.58%	14,438 $878,000
Q4 2020 Feb 12, 2021	SELL	$36.6 - $48.67 $191,271 - $254,349	-5,226 Reduced 27.46%	13,806 $648,000
Q3 2020 Nov 16, 2020	SELL	$35.39 - $40.57 $36,734 - $42,111	-1,038 Reduced 5.17%	19,032 $708,000
Q2 2020 Aug 14, 2020	SELL	$27.72 - $43.0 $32,903 - $51,041	-1,187 Reduced 5.58%	20,070 $733,000
Q1 2020 May 06, 2020	SELL	$23.53 - $52.61 $181,204 - $405,149	-7,701 Reduced 26.59%	21,257 $650,000
Q4 2019 Feb 04, 2020	SELL	$43.83 - $51.36 $139,817 - $163,838	-3,190 Reduced 9.92%	28,958 $1.48 Million
Q3 2019 Nov 06, 2019	SELL	$43.71 - $50.92 $325,770 - $379,506	-7,453 Reduced 18.82%	32,148 $1.52 Million
Q2 2019 Aug 08, 2019	SELL	$43.93 - $49.67 $176,422 - $199,474	-4,016 Reduced 9.21%	39,601 $1.97 Million
Q1 2019 May 10, 2019	SELL	$40.87 - $45.72 $339,302 - $379,567	-8,302 Reduced 15.99%	43,617 $1.86 Million
Q4 2018 Feb 07, 2019	SELL	$38.24 - $47.77 $145,617 - $181,908	-3,808 Reduced 6.83%	51,919 $2.13 Million
Q2 2018 Oct 02, 2018	BUY	$43.6 - $48.46 $60,516 - $67,262	1,388 Added 2.55%	55,727 $2.43 Million
Q1 2018 May 14, 2018	BUY	$44.08 - $54.77 $219,430 - $272,645	4,978 Added 10.08%	54,339 $2.49 Million
Q4 2017 Feb 13, 2018	BUY	$50.56 - $55.73 $112,344 - $123,832	2,222 Added 4.71%	49,361 $2.5 Million
Q3 2017 Nov 14, 2017	BUY	$46.68 - $51.95 $70,160 - $78,080	1,503 Added 3.29%	47,139 $0
Q2 2017 Aug 14, 2017	BUY	N/A	206 Added 0.45%	45,636 $2.51 Million
Q1 2017 Aug 17, 2017	BUY	N/A	40,887 Added 900.0%	45,430 $2.4 Million
Q1 2017 Aug 14, 2017	BUY	N/A	4,543	4,543 $312,000

Others Institutions Holding MET

# of Institutions

1,474

Shares Held

491M

Call Options Held

6.75M

Put Options Held

10M

View Full List

About METLIFE INC

Ticker MET
Exchange NYSE
Sector Financial Services
Industry Insurance—Life
Shares Outstandng 797,614,016
Market Cap $64B
Description
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...

More about MET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Metlife Inc Transaction History